Potter disease type 1

From WikiMD's Food, Medicine & Wellness Encyclopedia

Potter's Syndrome Type 1 or Potter Sequence Type 1 is a rare congenital disorder characterized by a series of typical physical abnormalities. The condition is named after Edith Potter, a pathologist who first described the syndrome in 1946.

Etiology[edit | edit source]

Potter's Syndrome Type 1 is caused by bilateral renal agenesis, a condition where both kidneys fail to develop during gestation. This leads to a lack of amniotic fluid, known as oligohydramnios, which in turn causes a series of developmental abnormalities.

Clinical Features[edit | edit source]

The most characteristic features of Potter's Syndrome Type 1 include pulmonary hypoplasia, or underdeveloped lungs, and distinctive facial features such as wide-set eyes, low-set ears, and a broad, flat nose. Other common features include limb deformities and, in males, undescended testes.

Diagnosis[edit | edit source]

Diagnosis of Potter's Syndrome Type 1 is typically made prenatally, through ultrasound examination. The absence of kidneys and bladder, along with the presence of oligohydramnios, are key indicators of the condition.

Prognosis[edit | edit source]

The prognosis for Potter's Syndrome Type 1 is generally poor, as the condition is typically fatal shortly after birth due to respiratory failure. However, with advances in neonatal care, some infants with the condition may survive for a period of time.

Treatment[edit | edit source]

There is currently no cure for Potter's Syndrome Type 1. Treatment is supportive and focuses on managing symptoms. This may include interventions such as mechanical ventilation for respiratory distress and dialysis for kidney failure.

See Also[edit | edit source]

Template:Congenital disorder

NIH genetic and rare disease info[edit source]

Potter disease type 1 is a rare disease.


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD